March 27 (Reuters) - Aeon Biopharma Inc AEON.A:
AEON BIOPHARMA ANNOUNCES CEO TRANSITION
AEON BIOPHARMA INC - MARC FORTH STEPS DOWN AS PRESIDENT AND CEO EFFECTIVE APRIL 4, 2025
AEON BIOPHARMA INC - JOST FISCHER APPOINTED INTERIM CEO
Source text: ID:nGNX8CwZFY
Further company coverage: AEON.A
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.